Search results
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 2 weeks agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Novavax's Q1 Results Are Overshadowed by Its Sanofi Partnership | The Motley Fool
The Motley Fool· 2 weeks agoNovavax (NVAX 47.63%) released its first-quarter earnings report on May 10, and the vaccine-focused biotechnology company's numbers reflected notable progress ...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 2 weeks agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. ...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
KFGO· 1 day agoBy Michael Erman (Reuters) - Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has ...
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now | The Motley Fool
The Motley Fool· 1 week agoIf you'd invested $10,000 in Novavax (NVAX 9.26%) a year ago, you would have made a risky bet. Prior...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 3 days agoOther vaccine stocks are climbing as well. Shares of CureVac which, like Moderna, develops messenger...
Novavax Stock Just Tripled. Is It Too Late to Buy? | The Motley Fool
The Motley Fool· 2 weeks agoAfter losing more than 90% of its value from a peak back in 2021, Novavax (NVAX -4.30%) stock has...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 2 weeks agoShares of the struggling vaccine developer Novavax (NASDAQ: NVAX) bounded 98.7% higher on Friday,...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 2 weeks agoNovavax will receive $500 million in upfront payments as well as a further $700 million if all...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 2 weeks ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...